Where Mednax Stands With Analysts
Mednax (NYSE:MD) has observed the following analyst ratings within the last quarter:
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Mednax
Looking Into Mednax's Return On Capital Employed
Mednax (NYSE:MD) brought in sales totaling $482.23 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 144.61%, resulting in a loss of $21.19 million.
Benzinga ·
Recap: Mednax Q1 Earnings
Mednax (NYSE:MD) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Mednax beat estimated earnings by 22.22%, reporting an EPS of $0.33 versus an estimate of $0.27.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Coverage From
Benzinga
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
